- Tandem Diabetes Care (TNDM, Financial) announces a collaboration with Abbott for integrated diabetes solutions.
- The partnership will incorporate Abbott's future glucose-ketone sensor with Tandem's insulin delivery systems.
- The initiative aims to enhance diabetes management and detect early ketone rise to prevent complications.
Tandem Diabetes Care, Inc. (TNDM), a leader in insulin delivery and diabetes technology, has announced a strategic agreement with Abbott to develop and commercialize innovative diabetes management solutions. This collaboration seeks to integrate Abbott's upcoming dual glucose-ketone sensor with Tandem's advanced insulin delivery systems, providing enhanced management options for diabetes patients.
The new sensor from Abbott, currently under development, is designed to combine glucose and ketone monitoring capabilities. The integration with Tandem's systems aims to empower patients by enabling faster and more informed health decisions, potentially reducing the risk of diabetic ketoacidosis—a severe diabetes complication.
"Integrating our advanced insulin delivery systems with Abbott’s future glucose-ketone sensor has the potential to help empower people with diabetes to take faster, more informed action to protect their health and improve outcomes," stated John Sheridan, CEO of Tandem Diabetes Care. The announcement underlines the ongoing partnership between Tandem and Abbott to deliver advanced diabetes care solutions.
Tandem Diabetes Care, based in San Diego, is known for its innovative insulin pumps like the Tandem Mobi and t:slim X2, both equipped with Control-IQ+ technology. This initiative reflects Tandem's commitment to reducing the burden of diabetes management and creating new possibilities for patients and healthcare providers.
It's important to note that the forward-looking statements in the announcement are subject to risks and uncertainties, which include technical challenges and regulatory hurdles that could affect the project timeline and integration outcome. Investors and stakeholders are advised to consider these factors when evaluating the collaboration's potential impact.
